CTLA4 and breast carcinoma: A meta-analysis reported that the CTLA-4 rs3087243 G>A polymorphism increased susceptibility to skin cancer.[20] However, a pooled-analysis also suggested that CTLA-4 rs3087243 G>A might decrease the risk of breast cancer.[21] Thus, these previous results were conflicting and ambiguous.